Mi Rim Choi
-
- Lymphoma Diagnosis and Treatment 3
- Dermatology top 5%
- Oncology top 10%
- Neutropenia and Cancer Infections 5
-
- T-cell and Retrovirus Studies 2
-
- Acute Lymphoblastic Leukemia research 10
-
- Childhood Cancer Survivors' Quality of Life 9
-
- Histone Deacetylase Inhibitors Research 6
-
- Transgenic Plants and Applications 3
-
- Nausea and vomiting management 2
- Co-authors
- Lee F. AllenGajanan BhatFrancine M. FossKerry J. SavagePoul KnoblauchAndrei R. ShustovAchiel Van HoofSteven M. Horwitz
- Journals
- Journal of Clinical Oncology (2 papers)Blood (8 papers)Journal of Pharmacology and Experimental Therapeutics (1 paper)
- Partner nations
- United StatesCanadaPoland
In The Last Decade
Mi Rim Choi
27 papers receiving 640 citations
Hit Papers
Peers
Comparison fields: 5 of 57
- Pathology and Forensic Medicine 255
- Dermatology 118
- Oncology 259
- Immunology 177
- Genetics 52
Countries citing papers authored by Mi Rim Choi
This map shows the geographic impact of Mi Rim Choi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mi Rim Choi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mi Rim Choi more than expected).
Fields of papers citing papers by Mi Rim Choi
This network shows the impact of papers produced by Mi Rim Choi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mi Rim Choi. The network helps show where Mi Rim Choi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mi Rim Choi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2023 | 2 | |
| 3 | 2022 | 18 | |
| 4 | 2021 | 4 | |
| 5 | 2018 | 10 | |
| 6 | 2017 | 3 | |
| 7 | 2017 | 3 | |
| 8 | 2016 | 15 | |
| 9 | 2016 | 0 | |
| 10 | 2016 | 4 | |
| 11 | 2016 | 21 | |
| 12 | Belinostat in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma: Results of the Pivotal Phase II BELIEF (CLN-19) Studybreakdown → | 2015 | 386 |
| 13 | 2014 | 16 | |
| 14 | 2014 | 3 | |
| 15 | 2014 | 2 | |
| 16 | 2011 | 13 | |
| 17 | 2010 | 19 | |
| 18 | 2009 | 20 | |
| 19 | 2008 | 2 | |
| 20 | 1994 | 2 |
About Mi Rim Choi
Mi Rim Choi is a scholar working on Pediatrics, Perinatology and Child Health, Complementary and Manual Therapy and Biotechnology, having authored 29 papers that have together received 647 indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (10 papers), Childhood Cancer Survivors' Quality of Life (9 papers), Histone Deacetylase Inhibitors Research (6 papers), Neutropenia and Cancer Infections (5 papers), Transgenic Plants and Applications (3 papers), Lymphoma Diagnosis and Treatment (3 papers), Nausea and vomiting management (2 papers) and T-cell and Retrovirus Studies (2 papers). The work is most often cited by research in Pathology and Forensic Medicine (255 citations), Dermatology (118 citations) and Oncology (259 citations). Mi Rim Choi has collaborated with scholars based in United States, Canada and Poland. Frequent co-authors include Lee F. Allen, Gajanan Bhat, Francine M. Foss, Kerry J. Savage, Poul Knoblauch, Andrei R. Shustov, Achiel Van Hoof, Steven M. Horwitz, Wojciech Jurczak and Jeanette K. Doorduijn. Their work appears in journals such as Journal of Clinical Oncology, Blood and Journal of Pharmacology and Experimental Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.